ICON plc (ICLR) PT Raised to $154 at Mizuho Securities
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/20/2026
Go back to ICON plc (ICLR) PT Raised to $154 at Mizuho Securities
February 21, 2019 10:03 AM EST
MolecularMD Corporation, a molecular diagnostic specialty laboratory that enables the development and commercialisation of precision medicines in oncology, announced today that it has been acquired by ICON plc (NASDAQ: ICLR). MolecularMDs extensive scientific and clinical biomarker experience expands ICONs capabilities in molecular diagnostic testing and also adds expanded testing platforms, including next-generation sequencing and immunohistochemistry, to ICONs laboratory service offering. MolecularMDs specialty central laboratory offering and associated client base extends ICONs reach into the support of precision... More
February 20, 2019 4:32 PM EST
ICON plc (NASDAQ: ICLR) reported Q4 EPS of $1.63, $0.03 better than the analyst estimate of $1.60. Revenue for the quarter came in at $679 million versus the consensus estimate of $675.88 million.
2019 outlook reaffirmed with revenue guidance in the range of $2,735 - $2,835 million and earnings per...
More
